Cipla acquires South Africa-based firm for ZAR 26 mn
New Delhi : Pharma major Cipla said its arm Medpro South Africa (Pty) Limited has signed an agreement to acquire 100 per cent stake in Anmarate (Pty) Limited, South Africa, for around ZAR 26 million. Anmarate (Pty) Limited has a turnover of ZAR 2.5 million for the financial year ending on February 29, 2016, Cipla Ltd said in a BSE filing.
The acquisition would strenghen the market position of the company, it said. The transaction is expected to be completed before April 14, 2017.
It said that the cost of acquisition is ZAR 26,253,659 subject to post closing of net working capital, not exceeding ZAR 30 million.
The company acquired 4000 shares of ZAR 1 each representing 100 per cent of the Anmarate's share capital.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd